Zambon Group S.p.a.

Elan Pharma International Limited

Daniele Bonadeo

Federico Stroppolo

Annibale Gazzaniga

Annibale Gazzaniga, Deceased

Gian F Fornasini

Paola Maria Gazzaniga, Legal Representative

Francesco Tocchini

Luigi Vigano'

Luigi Vigano

Alessandro Saudino

Aberto Pagano

Luigi Virgano'

Alberto Riccardi

Franco Ciccarello

By Paola Gazzaniga, Legal Representative

Alberto Pagano

A process for making a granulate composition suitable to the preparation of an oral solid form that can disintegrate rapidly inside the buccal cavity is provided as well as the granulate compositions and obtained.

Process for the preparation of a granulate suitable to the preparation

Liquid pharmaceutical composition for oral use containing

Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl)

A syrup containing N-acetyl-cysteine, stable for at least two years, having pleasant taste and smell, consists of an aqueous solution of NAC, a sweetening agent and a thickening agent. The solution can also contain a flavoring agent and a preservative. The pH is between 5 and 8.

Syrup containing N-acetyl-cysteine

Pharmaceutical compositions for topical use containing

Pharmaceutical compositions having analgesic activity containing (S)-2-(6-methoxy-2-naphthyl)-propionic acid as active ingredient and arginine, useful for the preparation of pharmaceutical forms for oral route, are described,

Pharmaceutical composition having analgesic activity

A pharmaceutical composition for oral use having analgesic activity containing a mixture of arginine and (S)-Ibuprofen in a molar ratio between 1.1 and 1.9 is described.

An ophthalmic pharmaceutical composition containing an association of N-acetyl-cysteine and polyvinylalcohol useful for the treatment of keratoconjunctivitis sicca.

Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and

A pharmaceutical composition for oral use containing the salt of S(+)-2-(4-isobutylphenyl)propionic acid with a basic aminoacid selected between L-arginine and L-lysine is described.

Pharmaceutical compositions containing the salts of

A process for the preparation of salts of 2-(4-isobutylphenyl)propionic acid with basic aminoacids, in particular L-arginine and L-lysine, is described.

Process for the preparation of salts of 2-(4-isobutylphenyl)propionic

A pharmaceutical aqueous solution for ophthalmic use comprising a nonsteroidal anti-inflammatory drug, having a carboxylic group, a decongestant drug and a mixture of a polysorbate and a poloxamer.

Pharmaceutical composition for ophthalmic use comprising a nonsteroidal

A transdermal therapeutic system in polymer matrix for the administration of bronchodilator drugs is described, in which the matrix comprises a mixture of medium and high molecular weight polyisobutylene in a ratio comprised between 1 and 2.3.

Growing community of inventors

Varese, Italy

Daniele Bonadeo